García-Rafanell J - Search Results

1

Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.

Merlos M, Gómez LA, Vericat L, García-Rafanell J, Forn J. Merlos M, et al. Pharmacology. 1990;40(4):211-7. doi: 10.1159/000138661. Pharmacology. 1990. PMID: 1697076

2

4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists.

Carceller E, Merlos M, Giral M, Bartrolí J, García-Rafanell J, Forn J. Carceller E, et al. J Med Chem. 1992 Feb 21;35(4):676-83. doi: 10.1021/jm00082a007. J Med Chem. 1992. PMID: 1542094

3

Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents.

Merlos M, Gómez LA, Giral M, Vericat ML, García-Rafanell J, Forn J. Merlos M, et al. Br J Pharmacol. 1991 Dec;104(4):990-4. doi: 10.1111/j.1476-5381.1991.tb12538.x. Br J Pharmacol. 1991. PMID: 1810607 Free PMC article.

4

Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.

Bartrolí J, Carceller E, Merlos M, García-Rafanell J, Forn J. Bartrolí J, et al. J Med Chem. 1991 Jan;34(1):373-86. doi: 10.1021/jm00105a058. J Med Chem. 1991. PMID: 1992139

5

The effect of fosfosal and acetylsalicylic acid on leukocyte migration and PGE2 concentration in experimentally induced acute inflammation.

Gómez LA, Ramis J, Julve J, García-Rafanell J, Forn J. Gómez LA, et al. Eur J Pharmacol. 1988 Mar 15;147(3):459-63. doi: 10.1016/0014-2999(88)90181-1. Eur J Pharmacol. 1988. PMID: 3163974

6

Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Giral M, Balsa D, Ferrando R, Merlos M, Garcia-Rafanell J, Forn J. Giral M, et al. Br J Pharmacol. 1996 Jul;118(5):1223-31. doi: 10.1111/j.1476-5381.1996.tb15527.x. Br J Pharmacol. 1996. PMID: 8818347 Free PMC article.

7

Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).

Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J. Merlos M, et al. J Pharmacol Exp Ther. 1997 Jan;280(1):114-21. J Pharmacol Exp Ther. 1997. PMID: 8996188

8

Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.

Fernández de Arriba A, Cavalcanti F, Miralles A, Bayón Y, Alonso A, Merlos M, García-Rafanell J, Forn J. Fernández de Arriba A, et al. Mol Pharmacol. 1999 Apr;55(4):753-60. Mol Pharmacol. 1999. PMID: 10101034

9

Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.

Izquierdo I, Merlos M, García-Rafanell J. Izquierdo I, et al. Among authors: garcia rafanell j. Drugs Today (Barc). 2003 Jun;39(6):451-68. doi: 10.1358/dot.2003.39.6.799450. Drugs Today (Barc). 2003. PMID: 12944997 Review.

10

(Pyridylcyanomethyl)piperazines as orally active PAF antagonists.

Carceller E, Almansa C, Merlos M, Giral M, Bartrolí J, García-Rafanell J, Forn J. Carceller E, et al. J Med Chem. 1992 Oct 30;35(22):4118-34. doi: 10.1021/jm00100a018. J Med Chem. 1992. PMID: 1433215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters